Dr. Hisham Ahamed

Dr Hisham Ahamed is a consultant cardiologist who manages adult patients with a wide range of cardiovascular conditions. He graduated in Medicine and Surgery from J.S.S Medical School, Mysore (Rajiv Gandhi University of Health Sciences), during which he was awarded the Gold Medal for the highest aggregate score in Pathology. Dr Ahamed undertook his internal medicine specialist training at the Sri Ramachandra Institute of Higher Education and Research, Chennai and distinguished himself as the recipient of the Gold Medal for the best outgoing candidate of his batch. He went on to pursue his cardiology specialist training at the Amrita Institute of Medical Sciences and Research, Kochi which was soon followed by a specialist fellowship in interventional cardiology at the same institute. Dr Ahamed has also undergone advanced fellowship training in cardiac MRI at the Hospital Cruz Vermelha, Lisbon.
In addition to his wide-ranging experience in interventional cardiology and device implants, Dr Ahamed has a passionate and dedicated focus on hypertrophic cardiomyopathy (HCM). He was instrumental in establishing the first and largest HCM Center of Excellence at the department of cardiology, Amrita Institute of Medical Sciences and Research in 2013. He has been mentored in the niche area of HCM care by Dr Barry Maron and Dr Martin Maron (Tuft’s HCM Centre, Boston), who are considered one of the foremost experts in HCM care worldwide. The Amrita HCM Centre has now become the preferred destination for HCM patients across India and neighboring countries for their comprehensive evaluation and management needs. Dr Ahamed has represented South Asia at the prestigious HCM summit (HCM Summit VI and VII) in 2017 and 2021. He has numerous publications in hypertrophic cardiomyopathy. Dr Ahamed currently is the co-investigator of studies which relate to the application of artificial intelligence and machine learning as it applies to cardiac imaging in hypertrophic cardiomyopathy.
Dr Ahamed is also the program lead for the Amrita Cardiovascular Genomics program. The Amrita Cardiovascular Genetics Services is the largest, comprehensive cardiovascular genomics service in India and has been founded on a decade of rich experience in managing inherited cardiovascular disease. Under his leadership, Over the last decade, the Amrita Cardiovascular Genetics Services has excelled at providing state of the art genetic testing, comprehensive clinical evaluation, treatment, risk assessment and risk reduction for a whole range of genetic cardiovascular disorders which include cardiomyopathies, channelopathies, aortopathies, premature ASCVD and congenital heart disease. Dr Ahamed has published widely in inherited cardiovascular disease and is also a Council Member of Cardiovascular Genomics (European Society of Cardiology).
Dr Ahamed is also the co-lead for the Amrita Cardio-Oncology program, and he currently serves as the vice president of the Asian Cardio-Oncology Society. The Amrita Cardio-Oncology Clinic at the Amrita Institute of Medical Sciences, Kochi, is one of the first initiatives of its kind in India, aiming to deliver contemporary evaluation and treatment strategies to promote cardiovascular health in cancer patients. Dr Ahamed has wide experience in managing cardiac amyloidosis, chemotherapy related cardiac toxicity and promoting cardiovascular health in cancer survivors. Dr Ahamed was the one of the principal organizers of the very first cardio-oncology summit in India, the National Cardio-Oncology Summit in 2017 held under the aegis of the International Cardio-Oncology Society.

• Amrita Hypertrophic Cardiomyopathy Registry and Clinic
  Project Lead, Amrita Hypertrophic Cardiomyopathy Registry and Clinic
  Founded the Amrita Hypertrophic Cardiomyopathy Registry and Clinic in 2013. This was the first comprehensive center of excellence for HCM care in India. This was established with mentorship under Dr Barry.J.Maron and Dr Martin.S. Maron from Tuft's HCM Center, Boston.
  (References : Importance and feasibility of creating hypertrophic cardiomyopathy centers in developing countries: the experience in India. Maron BJ. Am J Cardiol. 2015 Jul 15;116(2):332-4. doi: 10.1016/j.amjcard.2015.04.027. Epub 2015 Apr 18.)
• Hypertrophic Cardiomyopathy Summit VI, Boston, USA
  Speaker : " HCM in the Developing World "
  Was an invited speaker : International Summit VI: Hypertrophic cardiomyopathy – A Contemporary and Treatable Genetic Disease: Diagnosis, Heart Failure Management, and Prevention of Sudden Death, held in Boston, MA, October 27-29, 2017, at the Seaport Hotel & World Trade Center. Spoke on "HCM in the developing world"and was the only invited speaker from the South Asian region.
• Chapter Author : "Hypertrophic Cardiomyopathy" in Tandon's Textbook of Cardiology (2018)
  Chapter Author : "Hypertrophic Cardiomyopathy" in Tandon's Textbook of Cardiology (2018)
  Co-authors : Dr Barry.J.Maron and Dr Martin.S.Maron
• National Cardio-Oncology Summit, 2017
  • Co-Founded India's first National Cardio- Oncology Society in 2017 (Secretary of the NCOS)
  • Co-Founded India's first National Cardio-Oncology Summit in 2017 (Ramada Hotel, 2017) under the auspices of Canadian Cardio Oncology Society and International Cardio-Oncology Society
  • Co-Director of the very first dedicated Cardio-Oncology service at Amrita Institute of Medical Sciences and Research, Kochi
  • Organizing Secretary of India's first National Cardio-Oncology Summit at Ramada Hotel and Resorts, 2017 under the auspices of Canadian Cardio Oncology Society and International Cardio-Oncology Society
• ICCG : Brisbane, Australia 2018
  International Clinical Cardiovascular Genetics , Brisbane (2018)
  Presented 3 cardiovascular genomics papers at the ICCG, 2018 held at Brisbane:
  • Clinical outcome and phenotypic expression of PRKAG2 Cardiomyopathy
  • Familial Non- Syndromic Thoracic Aortic Dissection and Thoracic Aneurysm with an MYH 11 mutation
  • Clinical Profile of a Large Family with Familial HCM and Sudden Cardiac Death with an Alpha- Tropomyosin mutation
• Annual Kerala State Echocardiography Meet, 2017
  Organizing secretary of the Kerala Chapter of the Annual Indian Academy of Echocardiography Meet in 2017 (Ramada Hotel, Kochi)
• Annual Indian Academy of Echocardiography (2016) at Madurai
  Best Case presentation - Award session
  Won the award for best case presentation at Annual Indian Academy of Echocardiography meeting at Madurai ( 2016 ) for "Carcinoid Heart Disease : Flushing out the diagnosis"
• Case Presentation : Awards Session (CSI HFCON 2019)
  PRKAG2 Cardiomyopathy : A South Asian Cohort
  Presented the paper : PRKAG2 Cardiomyopathy : A South Asian Cohort at National CSI HFCON, 2019 during the Awards Session.
• Amrita Cardiovascular Genomics Service, 2015
  Founded the Amrita Cardiovascular Genomics Service, the first dedicated cardiovascular genomics service in the region. The service addresses all aspects of evaluation of inherited cardiovascular disease of patients and family screening along with advanced next generation sequencing and genetic counseling.

• Interventional Cardiology
  • Coronary angiograms
  • Coronary angioplasty
  • Rotablation
  • TAVR team member
  • EVAR team member
  • Advanced Coronary Imaging and Physiology Assessment ( IVUS, OCT, FFR )
  • Permanent Pacemaker Implants, AICD Implants, CRT Implants
• Hypertrophic Cardiomyopathy And Hcm Phenocopies
  • HCM Genetics
  • HCM Diagnosis, risk stratification and management
  • HCM – Advanced cardiac imaging and risk stratification
• Inherited Cardiovascular Disease
  • Next generation sequencing and genetic counseling
  • Next generation sequencing and interpretation
  • Genetic counseling for families
  • Evaluation of sudden cardiac death in the young
• Database Building And Statistical Analysis
• Advanced Cardiac Imaging : Echocardiography And Cardiac MRI
• Clinical Management And Epidemiology Of Heart Failure

Books

• Chapter Author : "Hypertrophic Cardiomyopathy" in Tandon's Textbook of Cardiology (2018), Wolters Kluwer India Pvt. Ltd

Journal Publications

• Left Atrial Approach to Septal Myectomy: Word of Caution. Varma PK, Ahamed H. Ann Thorac Surg. 2018 Nov;106(5):1591- 1592. doi: 10.1016/j.athoracsur.2018.05.006. Epub 2018 Jun 5 – Annals of Thoracic Surgery
• Posterior mitral leaflet plication for hypertrophic obstructive cardiomyopathy. Varma PK, Krishna N, Ahamed H, Madassery S. Asian Cardiovasc Thorac Ann. 2018 Jun;26(5):400-403. doi: 10.1177/0218492318773590. Epub 2018 Apr 18. – Asian Cardiovascular Thoracic Annals
• Letter by Ahamed and Subramanian Regarding Article “Missense Mutations in the FLNC Gene Causing Familial Restrictive Cardiomyopathy”. Ahamed H, Subramanian M. Circ Genom Precis Med. 2019 Jul;12(7):e002587. doi: 10.1161/CIRCGEN.119.002587. Epub 2019 Jul 15 – Circulation : Genomics and Precision Medicine
• Subramanian, M & Ahamed, Hisham & Mathew, N. (2017). Familial restrictive cardiomyopathy: A novel troponin mutation. Indian Heart Journal. 69. S87-S88. 10.1016/j.ihj.2017.09.107. Indian Heart Journal
• Subramanian, M & Ahamed, Hisham & Mathew, N. (2017). The prognostic value of right ventricular dysfunction in stress cardiomyopathy. Indian Heart Journal. 69. S80.10.1016/j.ihj.2017.09.087 – Indian Heart Journal
• Srinivasalu, Vijay & Subramaniam, M & Shanmugam, Arul & Philip, A & Susan, A & Prabhu, R & Unni, M & Sidharthan, Neeraj & Jose, Wesley & Nv, Smitha & Ahamed, Hisham & Mathew, N & Pavithran, Keechilat. 1025PIndependent predictors of one year mortality – Annals of Oncology
• Subramanian, M & Peravali, S & Ahamed, HISHAM & Mathew, NAVIN. (2019). P112Arrhythmogenic right ventricular cardiomyopathy and sick sinus syndrome : a potential overlap syndrome. European Heart Journal – Cardiovascular Imaging. 20.10.1093/ehjci/jez110.01 European Heart Journal : Cardiovascular Imaging

Conference Papers

ICCG : Brisbane, Australia 2018 – International Clinical Cardiovascular Genetics , Brisbane (2018)

Presented 3 cardiovascular genomics papers at the ICCG, 2018 held at Brisbane :

• Clinical outcome and phenotypic expression of PRKAG2 Cardiomyopathy
• Familial Non- Syndromic Thoracic Aortic Dissection and Thoracic Aneurysm with an MYH 11 mutation
• Clinical Profile of a Large Family with Familial HCM and Sudden Cardiac Death with an Alpha- Tropomyosin mutation

Presentations and Invited Lectures

Hypertrophic Cardiomyopathy Summit VI, Boston, USA – Speaker : “HCM in the Developing World”

Was an invited speaker : International Summit VI: Hypertrophic cardiomyopathy – A Contemporary and Treatable Genetic Disease: Diagnosis, Heart Failure Management, and Prevention of Sudden Death, being held in Boston, MA, October 27-29, 2017, at the Seaport Hotel & World Trade Center. Spoke on “HCM in the developing world”and was the only invited speaker from the South Asian region

• Hypertrophic Cardiomyopathy Summit VI, Boston, USA Speaker : “HCM in the Developing World”
• Presentation : “Assessment of Mitral Regurgitation by Echo” at CSI Kerala Meeting, 2014 (Kozhikode) (Invited Lecture)
• Presentation : “Flushing out the diagnosis” at CSI National CPC session, 2013 (Bangalore)
• Presentation : “Carcinoid heart disease” at Indian Academy of Echocardiography, 2016 (Madurai)
• Presentation : “FFR guided intervention for side branch in bifurcation lesions” at CSI Kerala,2015 (Kochi)(Invited Lecture)
• Presentation : “Ivabradine : Early is better in heart failure” at Society for Heart Failure and Transplantation, 2018 (Coimbatore)(Invited Lecture)
• Presentation : “Genetic testing in HCM : Practical Considerations” at Cardiovascular Genomics Update, 2018 (Chennai) (Invited Lecture)
• Presentation : “A Right atrial surprise” at Indian Academy of Echocardiography, Kerala Chapter,2015 (Kozhikode)
• Presentation : “Echo in the Emergency Room” at Annual Emergency Medicine update, AIMS, 2016 (Kochi)(Invited Lecture)
• Presentation : “Cost-effectiveness analysis of heart failure therapies” at Society for Heart Failure and Transplantation, 2016 (Kozhikode) (Invited Lecture)
• Presentation : “Inotropes : Clinical indications and limitations” at AIMS Heart Failure Update for Clinicians, 2018 (Kochi) ( Invited Lecture)
• Presentation : “Chemotherapy induced cardiotoxicity” at CSI HFCON, Kochi (2019) (Invited Lecture)
• Presentation : “Introduction to Cardio-Oncology : A New Sub-specialty” at National Cardio-Oncology Society, Kochi (2017)
• Presentation : “Unmet needs of current heart failure management” at Heart Failure Symposium, Marriott Kochi (2017) (Invited Lecture)
• Presentation : “ARNI – A new era in medical management of heart failure” at Indian Medical Association CME Update, Aluva (2017) (Invited Lecture)
• Presentation : “ARNI – newer paradigms in cardiovascular and renal outcomes” at Indian Medical Association CME Update, Tirur (2018) (Invited Lecture)
• Presentation : “10 essential lessons from heart failure guidelines” at Heart Failure Symposium at AIMS, Kochi (2018)
• Presentation : “The concept of ARNI in heart failure management” at Heart Failure Symposium at Karothukuzhi Hospital, Kochi (2018) (Invited Lecture)
• Presentation : “SGLT2 inhibitors and cardiovascular outcomes” at Diabetes Update, Palghat (2018) ( Invited Lecture)
• Presentation : “SGLT2 inhibitors : Role in diabetes and heart failure” at Holiday Inn Diabetes Care Symposia, Kochi (2017) (Invited Lecture)
• Presentation : “Role of SGLT2 inhibitors in modulating cardiovascular outcomes in diabetes mellitus” at Diabetes Today Symposium, Trivandrum (2019) (Invited Lecture)
• Presentation : “Updates in diabetes management – Role of SGLT2 inhibitors in modulating cardiovascular risk” at Diabetes and Heart Failure Update, Gokulam Hotel, Kochi (2017) (Invited Lecture)
• Presentation : “Advances in Diabetes Management : Cardiovascular outcome data” at Diabetes and Cardiovascular disease CME Update, Holiday Inn Kochi (2018) (Invited Lecture)
• Presentation : “Advances in antiplatelets : Focus on ACS management” Webinar at Holiday Inn, Kochi (2016) (Invited Lecture)
• Presentation : “Ticagrelor : Newer antiplatelet inhibition in ACS” at Physician Club Symposium Update, Thodupuzha (2016) (Invited Lecture)
• Presentation : “ Ticagrelor : Role in ACS and stable ischemic heart disease” : CAD Symposium at Karothukuzhi Hospital, Aluva (2018)
• Presentation : “Evolving trends in standard of care in ACS management” at Indian Medical Association CME Update, Cherthala (2019) (Invited Lecture)
• Presentation : “Pharmacoinvasive strategy for STEMI” at STEMI symposium, at Marriott Hotel, Kochi (2017) (Invited Lecture)
• Presentation : “Standards of ambulance care in STEMI and STEMI Network models” at STEMI Update at Marriott Hotel, Kochi (2017) (Invited Lecture)
• Presentation : “Newer P2Y12 inhibitors in clinical practice” at Indian Medical Association CME Update, Angamaly (2017) (Invited Lecture)
• Presentation : “Updates in ACS management” at ACS Symposium at AIMS, Kochi (2018) (Invited Lecture)
• Presentation : “Human beings – Prisoners of lifestyle diseases” at InQ, Kochi (2018) (Invited Lecture)
• Presentation : “10 lessons in lipid management” at Cochin Lives CME Update, Kochi (2018) (Invited Lecture)
• Presentation : “Managing hypertension and heart failure in COPD patients” at Indian Medical Association CME Update, Thodupuzha (2019) (Invited Lecture)
• Presentation : “HCM – A contemporary treatable disease” at Indian Medical Association CME Update, Kottayam (2017) (Invited Lecture)
• Presentation : “HCM – A contemporary treatable disease” at Indian Medical Association CME Update, Thodupuzha (2017) (Invited Lecture)
• Presentation : “HCM – A contemporary treatable disease” at Indian Medical Association CME Update, Kollam (2018) (Invited Lecture)
• Presentation : “HCM – A contemporary treatable disease” at Indian Medical Association CME Update, Kodungalur (2018) (Invited Lecture)
• Presentation : “HCM – A contemporary treatable disease” at Indian Medical Association CME Update, Thiruvalla (2018) (Invited Lecture)
• Presentation : “HCM – Evolving trends and contemporary management” at Amrita HCM Conclave, Kochi (2018) (Invited Lecture)
• Presentation : “Highlights of preventive aspects of non-communicable diseases” at Amrita Community Medicine CME Update, Kochi (2018) ( Invited Lecture)
• Presentation : “Nitrates – Evolving usage and current clinical indications” at Cardiology Monthly CME Webinar at Karothukuzhi Hospital, Kochi (2019)
• Presentation : “DPP-4 inhibitors : Current indications and cardiovascular outcome data” at Diabetes Care Symposium, Holiday Inn Kochi (2018) (Invited Lecture)
• Presentation : “Aortic valve anatomy in the TAVR Era” at AIMS TAVR Symposium at Crowne Plaza, Kochi (2017)
• Presentation : “Indications and utility of vitamin K antagonist oral anticoagulation in the era of NOAC” at Anticoagulation Symposium at Karothukuzhi Hospital, Kochi (2016)
• Presentation : “Sudden Cardiac Death in the Young” at Indian Medical Association CME Update, Madhya Kerala IMA, Kochi (2017)

• ACLS certified
• ACLS instructor course – Certified ACLS instructor

• Cardiology Society of India (CSI)
• Interventional Council Kerala (ICCK)
• International Cardio-oncology Society (ICOS)
• Society for Coronary Angiography and Interventions (SCAI)
• European Society of Cardiology (ESC)

National Cardio-Oncology Summit, 2017

• Co-Founded India's first National Cardio- Oncology Society in 2017 (Secretary of the NCOS)
• Co-Founded India's first National Cardio-Oncology Summit in 2017 (Ramada Hotel, 2017) under the auspices of Canadian Cardio Oncology Society and International Cardio-Oncology Society
• Co-Director of the very first dedicated Cardio-Oncology service at Amrita Institute of Medical Sciences and Research, Kochi
• Organizing Secretary of India's first National Cardio-Oncology Summit at Ramada Hotel and Resorts, 2017 under the auspices of Canadian Cardio Oncology Society and International Cardio-Oncology Society

Annual Kerala State Echocardiography Meet, 2017

Organizing secretary of the Kerala Chapter of the Annual Indian Academy of Echocardiography Meet in 2017 (Ramada Hotel, Kochi)